Finally, our data suggests that Cav-1 depletion in pancreatic cancer cells affects various pathways, particularly the JAK/STAT pathway, by decreasing activation of JAK2 and STAT3 and by increasing SOCS2, PIAS3, and DUSP5 inhibitory signals. The gene discussed is CAV1; the disease is familial pancreatic carcinoma.